Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06409065 · ClinicalTrials.gov registry record · NA

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

A NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06409065: Recruiting NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

NCT06409065 is a NA study of Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06409065, a NA study of Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The goal of this behavioral research study is to learn about the effects of two different supportive care programs on patients' and their family caregivers' psychological wellbeing and overall quality of life.

Primary Outcome

Participants will complete the Center for Epidemiologic Studies Depression Scale (CES-D), a 20-item self-report measure focusing on the affective component of depression, which is appropriate as patients may experience somatic symptoms due to treatment toxicities rather than depression.

Conditions Studied

Interventions

  • BEHAVIORAL Meditation Program

Study Locations (1)

Texas

  • MD Anderson - Houston

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-01-09
Est. Completion 2028-08-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What NCT06409065 shows while recruiting

NCT06409065 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Meditation Program is the first listed.

NCT06409065 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06409065 about?

NCT06409065 is a clinical study titled "Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers". The goal of this behavioral research study is to learn about the effects of two different supportive care programs on patients' and their family caregivers' psychological wellbeing and overall quality of life.

What is the current status of trial NCT06409065?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-01-09. Estimated completion is 2028-08-31.

What conditions does trial NCT06409065 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06409065?

The interventions under investigation include: Meditation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06409065?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06409065 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06409065's enrollment target sits among peer trials

400 148th of 615 higher than 464 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06409065, the US trial registry maintained by the National Library of Medicine. NCT06409065 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.